Lv2
102 积分 2024-08-06 加入
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
16小时前
已完结
Mechanisms of neurotransmitter transport and drug inhibition in human VMAT2
3个月前
已完结
Discovery and Characterization of a Bicyclic Peptide (Bicycle) Binder to Thymic Stromal Lymphopoietin
7个月前
已完结
Structural insight into hormone recognition by the natriuretic peptide receptor‐A
8个月前
已完结
Architecture and activation of single-pass transmembrane receptor guanylyl cyclase
8个月前
已完结
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
10个月前
已完结
Design, Synthesis, and Biological Evaluation of Aminoindazole Derivatives as Highly Selective Covalent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR4
1年前
已完结
皖公网安备34019202002308
